143 related articles for article (PubMed ID: 31764072)
1. Activated PD-1+ CD4+ T cells represent a short-lived part of the viral reservoir and predict poor immunologic recovery upon initiation of ART.
Eller MA; Hong T; Creegan M; Nau ME; Sanders-Buell E; Slike BM; Krebs SJ; Ratto-Kim S; McElrath MJ; Katabira ET; Bolton DL; Michael NL; Robb ML; Tovanabutra S; Baeten JM; Sandberg JK
AIDS; 2020 Feb; 34(2):197-202. PubMed ID: 31764072
[TBL] [Abstract][Full Text] [Related]
2. Programmed death-1 expression on CD4⁺ and CD8⁺ T cells in treated and untreated HIV disease.
Cockerham LR; Jain V; Sinclair E; Glidden DV; Hartogenesis W; Hatano H; Hunt PW; Martin JN; Pilcher CD; Sekaly R; McCune JM; Hecht FM; Deeks SG
AIDS; 2014 Jul; 28(12):1749-58. PubMed ID: 24871455
[TBL] [Abstract][Full Text] [Related]
3. Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.
Hunt PW; Cao HL; Muzoora C; Ssewanyana I; Bennett J; Emenyonu N; Kembabazi A; Neilands TB; Bangsberg DR; Deeks SG; Martin JN
AIDS; 2011 Nov; 25(17):2123-31. PubMed ID: 21881481
[TBL] [Abstract][Full Text] [Related]
4. Subclinical Cytomegalovirus DNA Is Associated with CD4 T Cell Activation and Impaired CD8 T Cell CD107a Expression in People Living with HIV despite Early Antiretroviral Therapy.
Christensen-Quick A; Massanella M; Frick A; Rawlings SA; Spina C; Vargas-Meneses M; Schrier R; Nakazawa M; Anderson C; Gianella S
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019052
[TBL] [Abstract][Full Text] [Related]
5. Human Immunodeficiency Virus Persistence and T-Cell Activation in Blood, Rectal, and Lymph Node Tissue in Human Immunodeficiency Virus-Infected Individuals Receiving Suppressive Antiretroviral Therapy.
Khoury G; Fromentin R; Solomon A; Hartogensis W; Killian M; Hoh R; Somsouk M; Hunt PW; Girling V; Sinclair E; Bacchetti P; Anderson JL; Hecht FM; Deeks SG; Cameron PU; Chomont N; Lewin SR
J Infect Dis; 2017 Mar; 215(6):911-919. PubMed ID: 28453847
[TBL] [Abstract][Full Text] [Related]
6. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.
Jain V; Hartogensis W; Bacchetti P; Hunt PW; Hatano H; Sinclair E; Epling L; Lee TH; Busch MP; McCune JM; Pilcher CD; Hecht FM; Deeks SG
J Infect Dis; 2013 Oct; 208(8):1202-11. PubMed ID: 23852127
[TBL] [Abstract][Full Text] [Related]
7. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.
Le T; Wright EJ; Smith DM; He W; Catano G; Okulicz JF; Young JA; Clark RA; Richman DD; Little SJ; Ahuja SK
N Engl J Med; 2013 Jan; 368(3):218-30. PubMed ID: 23323898
[TBL] [Abstract][Full Text] [Related]
8. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.
Cillo AR; Hilldorfer BB; Lalama CM; McKinnon JE; Coombs RW; Tenorio AR; Fox L; Gandhi RT; Ribaudo H; Currier JS; Gulick RM; Wilkin TJ; Mellors JW
AIDS; 2015 Oct; 29(16):2121-9. PubMed ID: 26544577
[TBL] [Abstract][Full Text] [Related]
9. Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART.
Pino M; Pereira Ribeiro S; Pagliuzza A; Ghneim K; Khan A; Ryan E; Harper JL; King CT; Welbourn S; Micci L; Aldrete S; Delman KA; Stuart T; Lowe M; Brenchley JM; Derdeyn CA; Easley K; Sekaly RP; Chomont N; Paiardini M; Marconi VC
PLoS Pathog; 2021 Aug; 17(8):e1009825. PubMed ID: 34449812
[TBL] [Abstract][Full Text] [Related]
10. T cells with high PD-1 expression are associated with lower HIV-specific immune responses despite long-term antiretroviral therapy.
Macatangay BJC; Gandhi RT; Jones RB; Mcmahon DK; Lalama CM; Bosch RJ; Cyktor JC; Thomas AS; Borowski L; Riddler SA; Hogg E; Stevenson E; Eron JJ; Mellors JW; Rinaldo CR;
AIDS; 2020 Jan; 34(1):15-24. PubMed ID: 31634201
[TBL] [Abstract][Full Text] [Related]
11. Intracellular HIV-1 RNA and CD4+ T-cell activation in patients starting antiretrovirals.
El-Diwany R; Breitwieser FP; Soliman M; Skaist AM; Srikrishna G; Blankson JN; Ray SC; Wheelan SJ; Thomas DL; Balagopal A
AIDS; 2017 Jun; 31(10):1405-1414. PubMed ID: 28358734
[TBL] [Abstract][Full Text] [Related]
12. Immunologic and Virologic Parameters Associated With Human Immunodeficiency Virus (HIV) DNA Reservoir Size in People With HIV Receiving Antiretroviral Therapy.
Blazkova J; Whitehead EJ; Schneck R; Shi V; Justement JS; Rai MA; Kennedy BD; Manning MR; Praiss L; Gittens K; Wender PA; Oguz C; Lack J; Moir S; Chun TW
J Infect Dis; 2024 Jun; 229(6):1770-1780. PubMed ID: 38128541
[TBL] [Abstract][Full Text] [Related]
13. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
[TBL] [Abstract][Full Text] [Related]
14. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.
Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F
Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071
[TBL] [Abstract][Full Text] [Related]
15. CD32
Noto A; Procopio FA; Banga R; Suffiotti M; Corpataux JM; Cavassini M; Riva A; Fenwick C; Gottardo R; Perreau M; Pantaleo G
J Virol; 2018 Oct; 92(20):. PubMed ID: 29976671
[TBL] [Abstract][Full Text] [Related]
16. Bone Marrow-Derived CD4
Hoang TN; Harper JL; Pino M; Wang H; Micci L; King CT; McGary CS; McBrien JB; Cervasi B; Silvestri G; Paiardini M
J Virol; 2019 Jan; 93(1):. PubMed ID: 30305357
[TBL] [Abstract][Full Text] [Related]
17. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
[TBL] [Abstract][Full Text] [Related]
18. CD4 T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy.
Boulassel MR; Chomont N; Pai NP; Gilmore N; Sékaly RP; Routy JP
J Clin Virol; 2012 Jan; 53(1):29-32. PubMed ID: 22019250
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of HIV reservoir decay and naïve CD4 T-cell recovery between immune non-responders and complete responders on long-term antiretroviral treatment.
Zhang LX; Song JW; Zhang C; Fan X; Huang HH; Xu RN; Liu JY; Zhang JY; Wang LF; Zhou CB; Jin L; Shi M; Wang FS; Jiao YM
Clin Immunol; 2021 Aug; 229():108773. PubMed ID: 34102315
[TBL] [Abstract][Full Text] [Related]
20. Levels of HIV-1 persistence on antiretroviral therapy are not associated with markers of inflammation or activation.
Gandhi RT; McMahon DK; Bosch RJ; Lalama CM; Cyktor JC; Macatangay BJ; Rinaldo CR; Riddler SA; Hogg E; Godfrey C; Collier AC; Eron JJ; Mellors JW;
PLoS Pathog; 2017 Apr; 13(4):e1006285. PubMed ID: 28426825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
